ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

In Brief: Columbia’s Marks Said To Be Cancer Panel New Member; Eight VCP Cregs Awarded

April 2, 1976

Obey Raps Reagan Administration For Blocking Report On Formaldehyde Danger

March 27, 1981

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994